Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0482 Transporter Info | ||||
Gene Name | SLC9A2 | ||||
Transporter Name | Sodium/hydrogen exchanger 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC9A2 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Cervix; Colon; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC9A2 gene, which in turn affects the expression or function of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC9A2 gene | [2] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC9A2 gene, which in turn affects the expression or function of the drug transporter Sodium/hydrogen exchanger 2. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in health condition | [3] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) has been reported to bind to the transcription of SLC9A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC9A2 gene | [4] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC9A2 gene, which in turn affects the expression or function of the drug transporter Sodium/hydrogen exchanger 2. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC9A2 gene in colorectal cancer condition | [5] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to activate the transcription of SLC9A2 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in prostate cancer condition | [6] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC9A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
ESR2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in breast cancer condition | [7] | ||||
TF Protein Name |
Estrogen receptor beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Estrogen receptor beta (ESR2) has been reported to bind to the transcription of SLC9A2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
GATA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in hematopoiesis condition | [8] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) has been reported to bind to the transcription of SLC9A2 gene in hematopoiesis condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
GATA6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC9A2 gene in gastric cancer condition | [9] | ||||
TF Protein Name |
Transcription factor GATA-6 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-6 (GATA6) has been reported to activate the transcription of SLC9A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in erythroleukemia condition | [10] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC9A2 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC9A2 gene in gastric cancer condition | [9] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) has been reported to activate the transcription of SLC9A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
SP1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in health condition | |||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Sp1 (SP1) has been reported to bind to the transcription of SLC9A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Transcriptional Phenomenon2 |
Activation of SLC9A2 gene in colon cancer condition | [11] | ||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (C2bbe1) | |||||
Detailed Description |
Transcription factor Sp1 (SP1) has been reported to activate the transcription of SLC9A2 gene in colon cancer condition, which leads to an increased expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
SP3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC9A2 gene in colon cancer condition | [11] | ||||
TF Protein Name |
Transcription factor Sp3 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (C2bbe1) | |||||
Detailed Description |
Transcription factor Sp3 (SP3) has been reported to activate the transcription of SLC9A2 gene in colon cancer condition, which leads to an increased expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in breast cancer condition | [12] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC9A2 gene in breast cancer condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC9A2 gene | [2] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC9A2 gene, which in turn affects the expression or function of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
CDX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in health condition | [3] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2) has been reported to bind to the transcription of SLC9A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in health condition | [13] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) has been reported to bind to the transcription of SLC9A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in prostate carcinoma condition | [14] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC9A2 gene in prostate carcinoma condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SPI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in K562 cells | [15] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC9A2 gene in K562 cells, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC9A2 gene | [16] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC9A2 gene, which in turn affects the expression or function of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in HESC condition | [13] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to bind to the transcription of SLC9A2 gene in HESC condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NFKB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in health condition | [3] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to bind to the transcription of SLC9A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC9A2 gene in health condition | [3] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to bind to the transcription of SLC9A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC9A2 gene in epithelial ovarian cancer condition | [17] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC9A2 gene in epithelial ovarian cancer condition, which leads to an increased expression of the drug transporter Sodium/hydrogen exchanger 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.